RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mezzion Pharma Co Stock

Mezzion Pharma Co ROA 2024

Mezzion Pharma Co ROA

-0.14

Ticker

140410.KQ

ISIN

KR7140410002

In 2024, Mezzion Pharma Co's return on assets (ROA) was -0.14, a -79.44% increase from the -0.67 ROA in the previous year.

Mezzion Pharma Co Aktienanalyse

What does Mezzion Pharma Co do?

Mezzion Pharma Co Ltd is a biopharmaceutical company based in South Korea, focused on the development and commercialization of therapeutics for the treatment of heart diseases. The company was founded in 2009 and has been listed on the Korea Stock Exchange since 2014. Mezzion Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Mezzion Pharma Co's Return on Assets (ROA)

Mezzion Pharma Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Mezzion Pharma Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Mezzion Pharma Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Mezzion Pharma Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Mezzion Pharma Co stock

What is the Return on Assets (ROA) of Mezzion Pharma Co this year?

The Return on Assets (ROA) of Mezzion Pharma Co is -0.14 undefined this year.

What was the ROA of Mezzion Pharma Co compared to the previous year?

The ROA of Mezzion Pharma Co has increased by -79.44% compared to the previous year.

What consequences do high ROA have for investors of Mezzion Pharma Co?

A high ROA is advantageous for investors of Mezzion Pharma Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Mezzion Pharma Co?

A low ROA can be unfavorable for investors of Mezzion Pharma Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Mezzion Pharma Co affect the company?

An increase in ROA of Mezzion Pharma Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Mezzion Pharma Co impact the company?

A reduction in the ROA of Mezzion Pharma Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Mezzion Pharma Co?

Some factors that can influence the ROA of Mezzion Pharma Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Mezzion Pharma Co important for investors?

The ROA of Mezzion Pharma Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Mezzion Pharma Co take to improve ROA?

To improve ROA, Mezzion Pharma Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Mezzion Pharma Co pay?

Over the past 12 months, Mezzion Pharma Co paid a dividend of 8.33 KRW . This corresponds to a dividend yield of about 0.03 %. For the coming 12 months, Mezzion Pharma Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Mezzion Pharma Co?

The current dividend yield of Mezzion Pharma Co is 0.03 %.

When does Mezzion Pharma Co pay dividends?

Mezzion Pharma Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mezzion Pharma Co?

Mezzion Pharma Co paid dividends every year for the past 0 years.

What is the dividend of Mezzion Pharma Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mezzion Pharma Co located?

Mezzion Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mezzion Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mezzion Pharma Co from 4/1/2013 amounting to 25 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2012.

When did Mezzion Pharma Co pay the last dividend?

The last dividend was paid out on 4/1/2013.

What was the dividend of Mezzion Pharma Co in the year 2023?

In the year 2023, Mezzion Pharma Co distributed 0 KRW as dividends.

In which currency does Mezzion Pharma Co pay out the dividend?

The dividends of Mezzion Pharma Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mezzion Pharma Co

Our stock analysis for Mezzion Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mezzion Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.